<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>2</title>
<title_fa>1</title_fa>
<short_title>3</short_title>
<subject>Literature &amp; Humanities</subject>
<web_url>http://idai.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>9</journal_id_issn>
<journal_id_issn_online>10</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>7</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>fa</language>
<pubdate>
	<type>jalali</type>
	<year>1390</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2012</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>4</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa>Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse</title_fa>
	<title></title>
	<subject_fa>پاتولوزی دهان، فک و صورت</subject_fa>
	<subject>Oral and Maxillofacial Pathology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa>&lt;p&gt; &lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;  PERP is a p53/p63-regulated gene encoding a desmosomal protein that plays a critical role in cell-cell adhesion and tumor suppression. &lt;/p&gt;&lt;p&gt; &lt;strong&gt;Study Design&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;  We evaluated PERP expression in different grades of oral dysplasia (34 cases) and at different stages of invasive squamous cell carcinoma (SCC), and correlated the latter with clinical outcome. A tissue microarray consisting of nondysplastic mucosa, carcinoma in situ, SCC, and nodal metastases from 33 patients with human papilloma virus–negative SCC was stained for PERP and E-cadherin. &lt;/p&gt;&lt;p&gt; &lt;strong&gt;Results&lt;/strong&gt; &lt;/p&gt;&lt;p&gt; Complete loss of PERP expression was associated with worse local control in patients with SCC. The 5-year local control rate was 91% for patients with partial PERP loss versus 31% for those with complete loss (P = .01). &lt;/p&gt;&lt;p&gt; &lt;strong&gt;Conclusions&lt;/strong&gt; &lt;/p&gt;&lt;p&gt; This is the first study to show that loss of PERP expression correlates with the transition to SCC and with increased local relapse in patients with oral cavity SCC. &lt;/p&gt;&lt;hr&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Source: &lt;/strong&gt;Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology &lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://www.oooojournal.net/article/S2212-4403(12)01677-X/abstract&quot; target=&quot;_blank&quot;&gt;&lt;font color=&quot;#0000ff&quot;&gt; Full Text&lt;/font&gt;&lt;/a&gt;&lt;/p&gt;</abstract_fa>
	<abstract></abstract>
	<keyword_fa></keyword_fa>
	<keyword></keyword>
	<start_page>0</start_page>
	<end_page>0</end_page>
	<web_url>http://idai.ir/browse.php?a_code=A-10-32-1505&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Christina</first_name>
	<middle_name></middle_name>
	<last_name>S. Kong</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846006872</code>
	<orcid>10031947532846006872</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Pathology, Stanford University, Stanford, California</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hongbin</first_name>
	<middle_name></middle_name>
	<last_name>Cao</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846006873</code>
	<orcid>10031947532846006873</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Stanford University, Stanford, California</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Shiley</first_name>
	<middle_name></middle_name>
	<last_name>Kwok</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846006874</code>
	<orcid>10031947532846006874</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pathology, Stanford University, Stanford, California</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Catherine</first_name>
	<middle_name></middle_name>
	<last_name>M.Nguyen</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846006875</code>
	<orcid>10031947532846006875</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pathology, Stanford University, Stanford, California</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Richard</first_name>
	<middle_name></middle_name>
	<last_name>S.Jordan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846006876</code>
	<orcid>10031947532846006876</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Orofacial Sciences, Pathology, and Radiation Oncology, University of California, San Francisco, California</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Veronica</first_name>
	<middle_name></middle_name>
	<last_name>G. Beaurdy</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846006877</code>
	<orcid>10031947532846006877</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Stanford University, Stanford, California</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Laura</first_name>
	<middle_name></middle_name>
	<last_name>D. Attardi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846006878</code>
	<orcid>10031947532846006878</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Stanford University, Stanford, California</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Quynh-Thu</first_name>
	<middle_name></middle_name>
	<last_name>Le</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846006879</code>
	<orcid>10031947532846006879</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiation Oncology, Stanford University, Stanford, California</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
